William Guyer, Chief Development Officer at Corcept Therapeutics, sold CORT on Aug 10, 2026
Data as of Oct 16
▼ SELL$544K4,770 shares at $114.04William Guyer Chief Development OfficerCORT Corcept Therapeutics Inc
- Traded
- Aug 10, 2026
- Disclosed
- Aug 12, 2026
- Filed
- 2 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
CORT since disclosure
−1.8%
after the sale
Similar stocks (XLV) since disclosure
+4.9%
XLV — its sector index fund
Change in closing price from Aug 12, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLWilliam Guyer Chief Development OfficerCORT Corcept Therapeutics Inc$1.3Mdisclosed Aug 12 · filed 2 days after the trade